GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » 3-Year EPS without NRI Growth Rate

Thyrocare Technologies (NSE:THYROCARE) 3-Year EPS without NRI Growth Rate : -12.50% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies 3-Year EPS without NRI Growth Rate?

Thyrocare Technologies's EPS without NRI for the three months ended in Mar. 2024 was ₹3.54.

During the past 12 months, Thyrocare Technologies's average EPS without NRI Growth Rate was 10.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was -12.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of Thyrocare Technologies was 24.20% per year. The lowest was -12.50% per year. And the median was 8.10% per year.


Competitive Comparison of Thyrocare Technologies's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Thyrocare Technologies's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's 3-Year EPS without NRI Growth Rate falls into.



Thyrocare Technologies 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Thyrocare Technologies  (NSE:THYROCARE) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Thyrocare Technologies 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies (NSE:THYROCARE) Business Description

Traded in Other Exchanges
Address
D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines